Follow
ARVINDEN
Title
Cited by
Cited by
Year
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly, RC Bhoyar, V Sardana, ...
Science 374 (6570), 995-999, 2021
3042021
Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India
B Jolly, N John, RC Bhoyar, N Majeed, V Senthivel, CP Fairoz, M Rophina, ...
Journal of Infection 83 (2), 237-279, 2021
642021
Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India
UB Singh, M Rophina, R Chaudhry, V Senthivel, K Bala, RC Bhoyar, ...
Journal of medical virology 94 (4), 1696-1700, 2022
252022
Identification of novel dysregulated circular RNAs in early‐stage breast cancer
AKDM Rao, VR Arvinden, D Ramasamy, K Patel, B Meenakumari, ...
Journal of Cellular and Molecular Medicine 25 (8), 3912-3921, 2021
232021
Regulation and functional significance of 5-hydroxymethylcytosine in cancer
VR Arvinden, AK Deva Magendhra Rao, T Rajkumar, S Mani
Epigenomes 1 (3), 19, 2017
92017
Systematic in-silico evaluation of the diagnostic impact of mpox genome variants in the current outbreak
A Vatsyayan, VR Arvinden, V Scaria
Molecular Diagnosis & Therapy 27 (2), 275-280, 2023
22023
Locus-specific enrichment analysis of 5-hydroxymethylcytosine reveals novel genes associated with breast carcinogenesis
D Ramasamy, AKDM Rao, M Balaiah, A Vittal Rangan, S Sundersingh, ...
Cells 11 (19), 2939, 2022
22022
Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies
P Gupta, SG Goswami, G Kumari, V Saravanakumar, N Bhargava, AB Rai, ...
Nature Communications 15 (1), 1794, 2024
2024
Genetic epidemiology of monogenic dyslipidemia and statin-associated adverse drug phenotypes in Indian population from whole-genomes of 1029 self-declared healthy individuals
M Imran, RC Bhoyar, A Jain, S Sahana, M Rophina, VR Arvinden, ...
Human Gene 39, 201252, 2024
2024
Impact of COVID-19 outbreak on healthcare workers in a Tertiary Healthcare Center in India: a cross sectional study
S Mirza, VR Arvinden, M Rophina, J Bhawalkar, U Khan, B Chothani, ...
Scientific Reports 14 (1), 1504, 2024
2024
Understanding the variant landscape, and genetic epidemiology of Multiple Endocrine Neoplasia in India
A Vatsyayan, J Bhardwaj, SJ Agrawal, BJ Saikia, VR Arvinden, ...
medRxiv, 2023.10. 20.23297293, 2023
2023
Scalable noninvasive amplicon-based precision sequencing (SNAPseq) for genetic diagnosis and screening of β-thalassemia and sickle cell disease using a next-generation …
P Gupta, VR Arvinden, P Thakur, RC Bhoyar, V Saravanakumar, ...
Frontiers in Molecular Biosciences 10, 2023
2023
Persistent SARS-CoV-2 infections in Immunocompromised hosts contribute to new variants
UB Singh, M Imran, R Chaudhry, B Jolly, K Bala, V Senthivel, A Srivastav, ...
OSF Preprints, 2022
2022
Genomic analysis of early SARS-CoV-2 breakthrough infections from the state of Kerala suggest a preponderance of variants of concern
VKM Niyas, A Shamnath, KJ Roshni, RC Bhoyar, AN Vimalraj, B Jolly, ...
OSF Preprints, 2021
2021
Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
PJ Beena, B Jolly, N John, RC Bhoyar, N Majeed, V Senthivel, CP Fairoz, ...
2021
Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India
J Beena Philomina, NJ Bani Jolly, CB Rahul, VS Nisha Majeed, CP Fairoz, ...
The Journal of Infection, 0
The system can't perform the operation now. Try again later.
Articles 1–16